Moleculin (NASDAQ: $MBRX) is a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant cancers and viruses.

ID:739230544307720194

linkhttp://moleculin.com calendar_today04-06-2016 23:01:10